Factors associated with tonic-clonic seizures in patients with drug-resistant mesial temporal epilepsy

Ali A Asadi-Pooya1, Cyrus Rostami1, Amin H Rabiei1

  • 1Jefferson Comprehensive Epilepsy Center, Department of Neurology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

Abstract

Insights

In mesial temporal epilepsy, epigastric auras are linked to fewer tonic-clonic seizures. This suggests specific brain regions involved in these auras may resist seizure generalization.

Area of Science:

  • Neurology
  • Epileptology
  • Clinical Neuroscience

Background:

  • Tonic-clonic seizures are a significant concern in epilepsy due to their association with increased morbidity.
  • Mesial temporal epilepsy is a common epilepsy syndrome, often drug-resistant.
  • Risk factors for tonic-clonic seizures in mesial temporal epilepsy remain under-investigated.

Purpose of the Study:

  • To identify risk factors associated with tonic-clonic seizures in patients with drug-resistant mesial temporal epilepsy.
  • To investigate the relationship between aura type and the occurrence of tonic-clonic seizures.

Main Methods:

  • Retrospective analysis of drug-resistant mesial temporal epilepsy patients who underwent epilepsy surgery.
  • Data collected prospectively from 1986-2014, including demographics, epilepsy history, and seizure types.
  • Statistical analysis to determine risk factors for preoperative tonic-clonic seizures.

Main Results:

  • The study included 275 patients (132 males, 143 females).
  • Aura type was significantly associated with perioperative tonic-clonic seizures.
  • Patients with epigastric auras reported tonic-clonic seizures less frequently than those with other auras or no auras (OR 0.37, P=0.001; OR 0.35, P=0.008).

Conclusions:

  • Epigastric auras may signify involvement of brain regions with limited connectivity, potentially hindering seizure generalization.
  • This finding could inform understanding of seizure propagation pathways in mesial temporal epilepsy.
  • Further research into the neuroanatomical basis of aura-related seizure control is warranted.

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.2K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.2K
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.7K
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.6K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
959
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.1K